This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "CSCR-044 Causative Agent"

From HL7Wiki
Jump to navigation Jump to search
 
(11 intermediate revisions by 4 users not shown)
Line 1: Line 1:
*'''Submitted by:''' Heath Frankel
+
Editing of Change Requests is restricted to the submitter and the co-chairs of the Clinical Statement Project. Other changes will be undone. Please add comments to the "discussion" page associated with this Change Request.
*'''Revision date:'''
 
*'''Submitted date:''' 6 Feb. 2006
 
  
Back to [[Change Requests]] page.
+
Back to [[Clinical Statement Change Requests]] page.
 +
{|width=100% cellspacing=0 cellpadding=2 border=1
 +
|| '''Submitted by:''' Heath Frankel
 +
|| '''Revision date:'''
 +
|-
 +
|| '''Submitted date:''' 6 Feb. 2006
 +
|| '''Change request Id:'''
 +
|-
 +
|}
  
 
== Issue ==
 
== Issue ==
Line 12: Line 18:
  
 
== Rationale ==
 
== Rationale ==
An allergy/intolerance is commonly represented as an observation/condition and the associated causative agent. To represent this simple/shortcut Allergy representation, the causative agent particpation directly associated from the obseravtion is required.
+
2012-05-02 Revision:
 +
Allergy/Intolerance is a condition in which an individual has a predisposition to adverse reactions of the allergic/intolerance reaction type. An adverse reaction is triggered by exposure of such individual to a susceptible agent/substance. The agent/substance is the cause or suspected to be the cause (until validated/confirmed by diagnostic investigations) of the adverse reaction given the condition.
 +
 
 +
It is important that Clinical Statement model contains Causative Agent (CAUS) participation from Observation to Agent choice box to support the inclusion of causative agent that may considered to have or potentially may trigger the onset of adverse reactions on exposure.
  
 
== Discussion ==
 
== Discussion ==
 +
23/2/06 TC discussion add a cautionary remark to state that the domain using this needs to make sure any ambiguity created by using short cuts must try to reduce any ambiguity as much as possible. HB suggested that if harmonisation passes this will trigger acceptance. CB suggested this may be impacted by harmonisation decision.
 +
 +
 +
== Recommended Action Items ==
 +
23/2/06 Action: Put change request on hold until harmonisation outcome known.
  
 +
18/5/06 Action: Hans to forward e-mail to Heath whether he is aware of the outcome (copy Dan Russler).
  
== Recommeded Action Items ==
+
1/2012 Reviewed at WGM, action on PCare to see if this still needed
  
 +
5/2012 Is still needed, action CS to carry out change request
  
 
== Resolution ==
 
== Resolution ==

Latest revision as of 16:10, 4 May 2012

Editing of Change Requests is restricted to the submitter and the co-chairs of the Clinical Statement Project. Other changes will be undone. Please add comments to the "discussion" page associated with this Change Request.

Back to Clinical Statement Change Requests page.

Submitted by: Heath Frankel Revision date:
Submitted date: 6 Feb. 2006 Change request Id:

Issue

Shortcut partcipation of a causative agent associated with an observation, e.g. allergy caused by peanuts.

Recomendation

  • Add proposed Causative Agent (CAUS) participation from Observation to Agent choice box (proposed in CSCR-043)

Rationale

2012-05-02 Revision: Allergy/Intolerance is a condition in which an individual has a predisposition to adverse reactions of the allergic/intolerance reaction type. An adverse reaction is triggered by exposure of such individual to a susceptible agent/substance. The agent/substance is the cause or suspected to be the cause (until validated/confirmed by diagnostic investigations) of the adverse reaction given the condition.

It is important that Clinical Statement model contains Causative Agent (CAUS) participation from Observation to Agent choice box to support the inclusion of causative agent that may considered to have or potentially may trigger the onset of adverse reactions on exposure.

Discussion

23/2/06 TC discussion add a cautionary remark to state that the domain using this needs to make sure any ambiguity created by using short cuts must try to reduce any ambiguity as much as possible. HB suggested that if harmonisation passes this will trigger acceptance. CB suggested this may be impacted by harmonisation decision.


Recommended Action Items

23/2/06 Action: Put change request on hold until harmonisation outcome known.

18/5/06 Action: Hans to forward e-mail to Heath whether he is aware of the outcome (copy Dan Russler).

1/2012 Reviewed at WGM, action on PCare to see if this still needed

5/2012 Is still needed, action CS to carry out change request

Resolution